WALTHAM, MA – Vicarious Surgical Inc. (NYSE:RBOT) reported that its Chief Financial Officer and Treasurer, William John Kelly, sold a total of 6,546 shares of the company's Class A common stock. The transaction, dated May 20, 2024, was carried out at a weighted average price of $0.388 per share, resulting in a total sale value of approximately $2,539.
The sale price per share ranged from $0.3799 to $0.3920, as disclosed in a footnote to the filing. The shares sold by Kelly were to cover tax withholding obligations related to the vesting of restricted stock units granted on May 19, 2022. Following the transaction, Kelly still owns 511,295 shares of Vicarious Surgical, indicating continued investment in the company's future.
Vicarious Surgical, a company specializing in orthopedic, prosthetic, and surgical appliances and supplies, is incorporated in Delaware and has its headquarters in Waltham, Massachusetts. The recent transaction was signed off by Erin Checka, Attorney-in-Fact, on May 21, 2024.
Investors and security holders of Vicarious Surgical can request detailed information about the individual sales prices from the CFO upon demand, as per the commitment made in the filing. The sale represents a routine financial move that executives sometimes make for personal financial management, often related to compensation or tax strategies.
InvestingPro Insights
Vicarious Surgical Inc. (NYSE:RBOT), while recently seeing its CFO sell shares, also presents a mixed financial picture according to the latest data. The company's market capitalization stands at a modest $52.56 million, reflecting the scale of the business in the competitive medical appliances and supplies sector. However, the company's P/E ratio is negative at -0.92, indicating that investors are currently not expecting earnings to cover the share price. This is further substantiated by the adjusted P/E ratio for the last twelve months as of Q1 2024, which remains negative at -0.87.
Despite these challenging metrics, RBOT has experienced significant returns in the short term, with a one-week price total return of 15.72% and a one-month price total return of 32.43%. These figures suggest a recent upswing in investor confidence or market reactions to specific company news or broader industry trends.
Two InvestingPro Tips that investors might find particularly relevant in this context are:
- RBOT holds more cash than debt on its balance sheet, which is a positive sign of financial stability and may provide a cushion against market volatility or unexpected expenses.
- Analysts have revised their earnings upwards for the upcoming period for RBOT, indicating that there may be positive developments or expectations for the company's financial performance in the near future.
For investors looking for more in-depth analysis and additional tips on Vicarious Surgical, there are 11 more InvestingPro Tips available at InvestingPro. Use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription, providing a more comprehensive understanding of RBOT's financial health and future prospects.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.